Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial

DSpace Repository

Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial

Author: Motzer, Robert J.; Russo, Paul; Haas, Naomi; Doehn, Christian; Donskov, Frede; Gross-Goupil, Marine; Varlamov, Sergei; Kopyltsov, Evgeny; Lee, Jae Lyun; Lim, Ho Yeong; Melichar, Bohuslav; Zemanova, Milada; Rini, Brian; Choueirim, Toni K.; Wood, Lori; Reaume, M. Neil; Stenzl, Arnulf; Chowdhury, Simon; McDermott, Ray; Michael, Agnieszka; Izquierdo, Miguel; Aimone, Paola; Zhang, Hong; Sternberg, Cora N.
Tübinger Autor(en):
Stenzl, Arnulf
Published in: European Urology (2021), Bd. 79, H. 3, S. 334-338
Verlagsangabe: Elsevier
Language: English
Full text: http://dx.doi.org/10.1016/j.eururo.2020.12.029
ISSN: 1873-7560
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)